Skip to main content

Animations

MJFF Publications

431 - 440 of 6516 Results
Title
Year
  • Year
  • 2018
  • 2015
  • 2012
  • 2022
  • 2023
  • 2023
  • 2023
  • 2022
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30126-1
    Citation Count: 125
  • Summary Details
    OPEN
    Title: Hippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple Sclerosis
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2015.11.022
    Citation Count: 145
  • Summary Details
    OPEN
    Title: Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc0
    DOI - Digital Object Identifier: 10.1371/journal.pone.0043099
    Citation Count: 141
  • Summary Details
    OPEN
    Title: A unifying model for the role of the ATG8 system in autophagy
    Journal Name: Journal of Cell Science
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1242/jcs.258997
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18443
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Antihypertensive drugs may not delay the symptom progression of Parkinson’s disease: A 2-year follow-up study
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18538
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Subsensory stochastic electrical stimulation targeting muscle afferents alters gait control during locomotor adaptations to haptic perturbations
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.isci.2023.107038
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Unaltered T cell responses to common antigens in individuals with Parkinson's disease
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by
    DOI - Digital Object Identifier: 10.1016/j.jns.2022.120510
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Spatially heterogeneous structure-function coupling in haemodynamic and electromagnetic brain networks
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2023.120276
    Citation Count: 28
  • Summary Details
    OPEN
    Title: PINK1: From Parkinson’s disease to mitophagy and back again
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3002196
    Citation Count: 22
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.